Curative effect of celoscope joint drug in treatment of endometriosis

Objective To study the curative effect of Celoscope joint drug in the treatment of endometriosis.Methods 92 patients from January 2007 to January 2011 who were diagnosed as endometriosis and treated by celoscope were slected,and patients were randomly divided into three groups,First group added gestrinone after celoscope,Second group added zoladex after celoscope,third group did't add drug after celoscope.The course of three groups were six months.All patients were followed up for 2 years.The response rate,recurrence rate,pregnancy rate and drug side effects were compared of three groups.Results The response rate,recurrence rate,pregnancy rate of first ang second group were better than third group,the differences were statistically significant(P0.05),but Second group were better than first group,the differences were statistically significant(P0.05).drug side effects of gestrinone group with liver function efect and high androgen symptoms was given priority to stop taking 1～6 months restore,zoladex group showed low estrogen for is the result of menopausal symptoms,stop drug in 1 to 2 months after recovery,low estrogen to reverse add therapy prevention.Conclusion Celoscope joint drug in treatment of endometriosis can reduce the patient's recurrence rate and improve the patient's pregnancy rate significantly.The curative effect of surgery joint zoladex in treatment of endometriosis is better than gestrinone,and is worthy of clinical application.